Shantam Pharmaceuticals Pvt Ltd
About Shantam Pharmaceuticals Pvt Ltd
Data last updated:
Shantam Pharmaceuticals Pvt Ltd is a private limited company based in Rajkot, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 January 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1995PTC024121. Its GSTIN is 24AAECS1210K1ZR (Gujarat).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹35 Lakh. It is led by directors Shaleshkumar Chandulal Bhalani and Bhaskar Chandulal Bhalani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 10th Floor Sweta Appt B/H Babby Land Kalavad Road, Rajkot, Gujarat, India – 360005.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.94 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹17.08 Lakh (net margin 1.7%) and EBITDA of ₹90.02 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 7% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Shantam Pharma. As per MCA filings, the company has open charges of ₹4.95 Cr and satisfied charges of ₹4.01 Cr on record. Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Shantam Pharmaceuticals Pvt Ltd's registered office is in Rajkot, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address10th Floor Sweta Appt B/H Babby Land Kalavad Road, Rajkot, Gujarat, India – 360005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shantam Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Shantam Pharmaceuticals operates one associated brand: Shantam Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a third-party manufacturer for pharmaceuticals. | shantampharmaceuticals.com |
Business activity
The main business activity of Shantam Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shantam Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Shantam Pharmaceuticals Pvt Ltd
FY 2024 filings availableShantam Pharmaceuticals Pvt Ltd reported revenue of ₹9.94 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 20% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹90.02 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shantam Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Shantam Pharmaceuticals Pvt Ltd
Shantam Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaleshkumar Chandulal Bhalani | Director | 13 Nov 2014 | 11 Years 11 Months | Current |
| Bhaskar Chandulal Bhalani | Director | 15 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Shantam Pharmaceuticals Pvt Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| I G Homoeo Remedies Private Limited | ₹9.97 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Tarun Biotech Private Limited | ₹9.96 Cr (FY 2025) | 21.0% | Aurangabad, Maharashtra, India | |||
| Base Metal Chlorinations Private Limited | ₹9.95 Cr (FY 2025) | -60.0% | Vadodara, Gujarat, India | |||
| Shantam Pharmaceuticals Pvt Ltdthis company | ₹9.94 Cr (FY 2025) | ₹17.08 Lakh | 1.7% | 20.0% | 11 | Rajkot, Gujarat, India |
| Gelmek Healthcare Private Limited | ₹9.92 Cr (FY 2025) | 28.0% | Moraiya, Ahmedabad, Gujarat, India | |||
| Konis Pharmaceuticals Private Limited | ₹9.91 Cr (FY 2025) | 3.0% | & Distt Solan Hp, Himachal Pradesh, India |
To see the full peer comparison of Shantam Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Shantam Pharmaceuticals Pvt Ltd is audited by DJM & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DJM & Co. | FY 2024 | 140689W |
Shareholding
The shareholding of Shantam Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shantam Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Aug 2022 | 100615925 | Axis Bank Limited | ₹4.15 Cr | Open | |
| 22 Jun 2022 | 100600454 | Axis Bank Limited | ₹80 Lakh | Open | |
| 28 Jan 2017 | 100077936 | Others | ₹1.39 Cr | Satisfied | |
| 15 Apr 2015 | 10567565 | Karnataka Bank Ltd. | ₹1.6 Cr | Satisfied | |
| 08 Mar 2004 | 90102344 | The Mehsana Co-Operative Bank Ltd | ₹15 Lakh | Satisfied |
To see the full charge records of Shantam Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 10 View all charges
Legal cases
Shantam Pharmaceuticals Pvt Ltd has 6 court cases on record: 1 filed by Shantam Pharmaceuticals, 5 filed against it. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
| High courts | 2 | 1 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Appeal | Filed against the company by Unison Pharmaceuticals Pvt. Ltd. and 3 others | Pending |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Unison Pharmaceuticals Pvt Ltd. | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against Union of India and 3 others | Disposed |
| District court, Wardha, Maharashtra | Court case (R.C.C.) | Filed against the company by State of Maharashtra | Disposed |
| District court, Nagpur, Maharashtra | Court case (R.C.C.) | Filed against the company by State of Maharashtra F. D. | Disposed |
To see the full case history of Shantam Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Shantam Pharmaceuticals Pvt Ltd has 6 MSME Form 1 returns on record between 2015 and 2024, listing 147 overdue payments to 47 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 47)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pharma Supply Agencies | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Accurate Gravures |
To see the full MSME payment records of Shantam Pharmaceuticals Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Shantam Pharmaceuticals Pvt Ltd has a workforce of 11 employees on its EPFO records as of Mar 26, 2025, across 1 active EPFO establishment.
GST
Shantam Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECS1210K1ZR | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shantam Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Shantam Pharmaceuticals Pvt Ltd has 8 board changes on record since 2011: 2 appointments and 6 cessations. The latest: Ajaykumar Jamnadas Sheth ceased to be Director on 14 Jul 2015.
18 earlier events are in the company report.
Frequently asked questions
Shantam Pharmaceuticals is an active private limited company based in Rajkot, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 January 1995 (31+ years old) and is registered under CIN U24230GJ1995PTC024121.
Shantam Pharmaceuticals has 2 current directors:
- Shaleshkumar Chandulal Bhalani - Director
- Bhaskar Chandulal Bhalani - Director
The latest financial statements of Shantam Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Shantam Pharmaceuticals is 24AAECS1210K1ZR, registered in Gujarat.
The CIN (Corporate Identification Number) of Shantam Pharmaceuticals is U24230GJ1995PTC024121. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shantam Pharmaceuticals has 6 court cases on record: 1 filed by the company and 5 filed against it. 1 is pending. Most are in the district courts.
Shantam Pharmaceuticals was incorporated on 06 January 1995, making it 31+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Shantam Pharmaceuticals by revenue are I G Homoeo Remedies Private Limited, Tarun Biotech Private Limited, Base Metal Chlorinations Private Limited, Gelmek Healthcare Private Limited, Konis Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ajaykumar Jamnadas Sheth ceased to be Director on 14 Jul 2015. Sureshbhai Kadavabhai Patel ceased to be Additional Director on 14 Jul 2015. Bhaskar Chandulal Bhalani was appointed as Director on 15 Dec 2014. Shantam Pharmaceuticals has 8 board changes on record in total.
Shantam Pharmaceuticals has 6 MSME Form 1 returns on record between 2015 and 2024, listing 147 overdue payments to 47 micro and small suppliers. The latest return was filed on 01 May 2024.
The registered office of Shantam Pharmaceuticals is at 10th Floor Sweta Appt BH Babby Land Kalavad Road, Rajkot, Gujarat, India – 360005.
Shantam Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.